Baxter International Inc (BAX)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$16.66

Buy

$16.67

arrow-down$-0.12 (-0.72%)

Prices updated at 02 Apr 2026, 20:06 EDT

Prices minimum 15 mins delay

Prices in USD

Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.

S&P 500

-0.06%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Mr. D. Brent Shafer

CEO

Mr. Andrew P. Hider

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

37,500

Head office

One Baxter Parkway

Deerfield

United States

60015

+1 224 948-2000

Global_CORP_Investor_Relations@baxter.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Michael R. Mcdonnell Director	-
Ms. Anita A. Zielinski Senior Vice President, Chief Accounting Officer, Controller and Interim Chief Financial Officer	-
Ms. Patricia B. Morrison Independent Director	0.12m
Dr. Stephen Newman Oesterle, M.D. Independent Director	0.14m
Mr. Jeffrey A. Craig Independent Director	0.15m
Ms. Amy A. Wendell Independent Director	0.12m
Ms. Nancy M. Schlichting Lead Independent Director	0.17m
Mr. D. Brent Shafer Chairman of the Board	0.70m
Mr. Andrew P. Hider Director, President, Chief Executive Officer Interim Group President, Medical Products and Therapies	0.50m
Dr. David S. Wilkes, M.D. Independent Director	0.12m
Mr. David S. Rosenbloom Executive Vice President and General Counsel	0.76m
Mr. Reazur Rasul Executive Vice President and Group President, Healthcare Systems and Technologies	0.80m
Mr. William A. Ampofo, II Independent Director	0.12m
Ms. Maria Cecilia Soriano Group President, Infusion Therapies & Technologies & Pharmaceuticals	0.67m
Ms. Jeanne K. Mason Executive Vice President and Chief Human Resources Officer	-
Mr. James W. Borzi Executive Vice President and Chief Supply Chain Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	77,827,325
Pzena Investment Management, LLC	70,046,251
Vanguard Group Inc	62,635,136
Dodge & Cox	56,999,970
Dodge & Cox Stock Fund	38,623,700

Director dealings

Date chevron-l-regular chevron-r-regular	Action
12 Dec 2025	-
01 Dec 2025	-
02 Sep 2025	-
02 Sep 2025	-
02 Sep 2025	-
02 Sep 2025	-
02 Sep 2025	-
02 Sep 2025	-
02 Jun 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 May 2025	-
06 Mar 2025	-
06 Mar 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.